Screening study of various immunomodulatory medicinal collections

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Introduction. At present, it has become clear that in almost all human diseases, both infectious and non-infectious nature, there are changes in the functioning of the immune system.

Based on the foregoing, it is concluded that it is necessary to develop and study immunomodulatory agents, especially immunomodulatory agents of plant origin, since immunotropic agents of plant origin act gently and practically do not cause disruptions in the immune system associated with autoimmune and autoreactive processes.

Objective: was a screening study of various immunomodulatory medicinal collections (MC).

Material and methods. The study of the immunomodulatory activity of various MCs was carried out on the model of prednisolone immunosuppression. It is known that prednisolone, like any glucocorticosteroid, has an immunosuppressive effect, and therefore is widely used in medicine to reduce immunity.

The object of the study were five different MCs in the form of a phytocollection.

Results. According to the results of the experiment, it was found that the MC – Hypericum perforatum (herb) – 3,0 g, Glycyrrhiza glabra (roots) – 3,0 g, Arctium lappa (roots) – 3,0 g, Taraxacum officinale (roots) – 3,0 g, Quercus robur (bark)– 3,0 g, Juglans regia (leaves) – 3,0 g, Urtica dioica (leaves) – 2,0 g, Melissa officinalis (herb) – 1,0 g, Chamomilla officinalis (flowers) – 1,0 g, Salvia officinalis (leaves) – 1,0 g has the highest immunomodulatory activity and is promising for studies as an immunomodulatory agent.

Conclusion. From the five different MCs, the most promising phytocombination with promising immunomodulatory activity was determined.

Full Text

Restricted Access

About the authors

Bakhtiyor Alisherovich Imamaliev

«Med Standart» Research Center

Author for correspondence.
Email: teokrat_1985@mail.ru
ORCID iD: 0000-0002-7526-5105

PhD in Pharmaceutical Sciences, Senior Sientific Researcher, Head of Scientific Center «Med Standart LLC»

Uzbekistan, Karasarai St., 343, Tashkent, 100049

Komila Zokirovna Alimkulova

Expertise and Standardization of Medicines, Medical Devices and Medical Equipment»
under the Ministry of Health of the Republic of Uzbekistan

Email: komila.yusupova@mail.ru
ORCID iD: 0000-0002-7806-937X

PhD in Pharmaceutical Sciences, leading specialist of the printing department of the State Unitary Enterprise «State Center for Expertise and Standardization of Medicines, Medical Devices and Medical Equipment» under the Ministry of Health of the Republic of Uzbekistan

Uzbekistan, st. Ozod, 16, passage K. Umarov, 100002, Tashkent

Abdurahmon Rasuljonovich Shokodirov

«Med Standart» Research Center

Email: abdurakhmon95@gmail.com
ORCID iD: 0000-0003-0858-2159

pharmacologist of the Scientific Center of Scientific Center «Med Standart LLC»

Uzbekistan, Karasarai St., 343, Tashkent, 100049

Flyura Faridovna Urmanova

Tashkent Pharmaceutical Institute

Email: flyura.urmanova@mail.ru
ORCID iD: 0009-0003-8636-5480

Professor of the Department of Pharmacognosy of Tashkent Pharmaceutical Institute, Doctor of Pharmaceutical Sciences, Professor

Uzbekistan, Aibek St., 45, Tashkent, 100015

References

  1. Khaitov R.M. Immunomodulators: myths and reality. Immunologiya. 2020; 41 (2): 101–6. https://doi.org/10.33029/0206-4952-2020-41-2-101-106 (in Russian)
  2. Pinegin B.V., Khaitov R.M. Modern principles of immunotropic drugs creation. Immunologiya. 2019; 40 (6): 57–62. doi: 10.24411/0206-4952-2019-16008 (in Russian)
  3. Imamaliev B.A., Alimkulova K.Z., Shokodirov R.R., Isajhanov M.S., Urmanova F.F. Evaluation of the impact of immunomodulatory phytocombination as a dry extract on humoral immunity. Farmatsiya. 2021; 70 (7): 53–6. https://doi.org/10/29296/25419218-202T-07-09 (in Russian)
  4. Dotsenko E.A., Rozhdestvensky D.A., Yupatov G.I. Immunodeficiencies and some immunomodulating agents. Bulletin of VSMU. 2014; 13 (3): 103–20 (in Russian)
  5. Guidelines for pre-clinical study of medicinal products. Part 1. (by ed. A.N. Mironov). Moscow: Grief and K, 2012; 944 (in Russian)
  6. Gulyamov Sh.Sh., Imamaliev B.A., Mamanov B.I. Study of the bioequivalence of drugs «Laferobion» and «Viferon». Pharmaceutical Bulletin of Uzbekistan. 2019; 3: 87–90 (in Russian)
  7. Reference Vidal. [Electronic edition]. Access mode:http://vidal.ru (in Russian)

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies